Detected ·
Jasper Therapeutics
$132M—
Jasper Therapeutics completed an all-stock acquisition of Kira Pharmaceuticals and secured ~$132M in new capital via private placement, co-led by Affinity Asset Advisors and Ikarian Capital. The combined immunology-focused biotech will advance a three-asset pipeline and remain listed on Nasdaq under JSPR.
- Website
- —
- —
- Amount
- $132 000 000 USD
- Stage
- —
- Event
- Funding round
- Detected
- 2026-07-18 00:03:57 UTC
- Signal ID
- 0c30d447-28e9-48d9-9903-2a26f418a514
As the API returns it
{
"id": "0c30d447-28e9-48d9-9903-2a26f418a514",
"created_at": "2026-07-18T00:03:57.535755Z",
"company_name": "Jasper Therapeutics",
"company_website_url": null,
"company_linkedin_url": null,
"event_type": "funding",
"funding_amount": 132000000,
"funding_currency": "USD",
"funding_stage": null,
"message": "*Jasper Therapeutics completed an all-stock acquisition of Kira Pharmaceuticals and secured ~$132M in new capital via private placement, co-led by Affinity Asset Advisors and Ikarian Capital. The combined immunology-focused biotech will advance a three-asset pipeline and remain listed on Nasdaq under JSPR.*"
}